tag:blogger.com,1999:blog-19598651.post8967839416046295385..comments2008-03-04T08:47:18.961-08:00Comments on Dr. Joe's E-News - A Diabetes Newsletter: TDZs and Cardiovascular OutcomesDr. Joehttp://www.blogger.com/profile/14401603517570061890noreply@blogger.comBlogger2125tag:blogger.com,1999:blog-19598651.post-33220513538606249882008-03-04T08:47:00.000-08:002008-03-04T08:47:00.000-08:00No. This article applies to both.No. This article applies to both.Dr. Joehttp://www.blogger.com/profile/14401603517570061890noreply@blogger.comtag:blogger.com,1999:blog-19598651.post-73822290852462896222008-02-29T00:05:00.000-08:002008-02-29T00:05:00.000-08:00Are you referring to the article entitled, "FDA Ro...Are you referring to the article entitled, "FDA Rosiglitazone Warning" by Bridget M. Kuehn?<BR/><BR/>Doesn't that study refer to Avandia and not Actos?Ronhttp://www.blogger.com/profile/13958965805896626611noreply@blogger.com